Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy

British Journal of Cancer

Volumn 75, Issue 6, 1997, Pages 903-909

  Findlay, Mpn ^a,d   Cunningham, D ^b   Morgan, G ^b   Clinton, S ^c   Hardcastle, A ^a   Aherne, G W ^d  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b North East Surrey College of Technology   (United Kingdom)

^c Department of Histopathology   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

5 fluorouracil; Antibody; Colorectal cancer; Immunohistochemistry; Thymidylate synthase; Tomudex

Indexed keywords

ALPHA2B INTERFERON; FLUOROURACIL; FOLIC ACID ANTAGONIST; POLYCLONAL ANTIBODY; RALTITREXED; THYMIDYLATE SYNTHASE; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; HUMAN; IMAGE ANALYSIS; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE LEVEL; TREATMENT OUTCOME;

EID: 0031053520     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.159     Document Type: Article

References (45)

1. Adenis A, Cunningham D, Van Cutscm E, Zalcberg J, Francois E, Schoraagel JH, Green M, Starkhammer H, Perez-Manga G and Seymore L ( 1994) Tomudex (ZD1694), a new active agent in the treatment of advanced colorectal cancer. Ann Oncol 5 (suppl. 8): 189
2. Aherne GW, Hardcastle A and New ton R ( 1992) Measurement of human thymidylate synthase (hTS) in cell lines using ELISA. Ann Oncol 3 (Suppl. 5): 77
3. Beck A, Etienne S, Cheradame S, Fischel JL, Formento P, Renée N and Milano G (1994) A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Ear J Cancer 30A: 1517-1522
4. Berger SH, Chung-Her J, Johnston LF and Berger, FG (19S7) Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol Pharmacol 28: 461-467
5. Cadman E and Heimer R ( 1986) Levels of [hymidylate synthetase during normal culture growth of LI 210 cells. Cancer Res 46: 1195-1198
6. Clark JL, Berger SH, Mittelman A and Berger FG (1987) Thymidylate.synthase gene amplification in a colon tumour resistant to fluoropyrimidine chemotherapy. Cancer Treat Rep 71: 261-265
7. Chu E, Zinn S, Boarman D and Allegra CJ (1990) Interaction of gamma interferon and 5-fluorouracil in H630 human colon carcinoma cell line. Cancer Res 50: 5834-5840
8. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renée N, Schneider M, Thyss A, Demard F and Milano G (1995) Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. 7 Clin Oncol 13: 1663-1670
9. Findlay MPN, Cunningham D, Hill ME, Ellis P, Young H, Hickish A, Hanrahan A, Watson M, Norman A, Evans C, Flower M and Ott R (1994) Protracted venous infusion 5FU interferon-o2b (Intron-A) in patients with advanced colorectal cancer: results of a phase III trial and a parallel study measuring tumour fluorodeoxyglucose w ith positron emission tomography. Proc Am Soc Clin Oncol 13:193
10. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerman DL, Fisher ER, Caplan R, Jones J, Lcrner H, Gordon P, Feldman M, Cruz A, Legault Poisson S, Wexler M, Lawrence W and Robidoux A (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABPprotocoI R-01.7A'// Cancer but 80: 21-29
11. Freemantle SJ, Aherne GW. Hardcastle A, Lunec J and Calvert AH (1991) Increases in thymidylate synthase protein levels measured using newly developed antibodies. Proc Ani Assoc Cancer Res 32: 360
12. Freemantle SJ, Jackman AL, Kelland LR, Calven AH and Lunec J (1995) Molecular characterisation of 2 cell lines selected for resistance to the folate-based TS inhibitor, ZD1694. Br J Cancer 71: 925-930
13. Hill M, Findlay MPN, Cunningham D, Norman A, Nicholson V, Hill A, Iveson A, Evans C, Joffee J, Nicholson M and Hickish T (1995) A Royal Marsden Phase III trial of weekly 5FU with and without interferon alpha in advanced colorectal carcinoma. 7 Clin Oncol 13: 1297-1303
14. Holgate C (1983) Surface membrane staining of immunoglobulins in paraffin sections of non-Hodgkin's lymphomas using immunogold-silver staining technique. 7 Clin Pathol36: 742-746
15. Horikoshi T, Danenberg K, Stadbauer THW, Volkenandt M. Shea LCC, Aigncr K, Gustavsson B, Leichman L, Prosing R, Ray M, Gigso NM, Spears CP and Danenberg PV (1992) Quantitation of thymidylate synthase, dihydrofolate reductase and DT diaphorase gene expression in human tumours using the polymerase chain reaction. Cancer Res 52: 108-116
16. Jackman AL and Calvert AH (1995) Folate based thymidylate synthase inhibitors to anticancer drugs. (1995) Ann Onco 6: 871-881
17. Jackman AL, Taylor GA, Gibson W, Kimbell R, Calvert AH, Judson IR and Hughes LR (1991) ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumour cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res 51: 5579-5586
18. Jackman AL, Kelland LR, Kimbell R, Brown M, Gibson W, Aheme GW, Hardcastle A and Boyle FT (1995a) Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. Br J Cancer 71: 914-924
19. Jackman AL, Farrugia DC, Gibson W, Kimbell R, Harrap KR, Stephens TC, Azab M and Boyle FT (19956) ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Ear J Cancer 31 A: 1277-1282
20. Jastreboff MM, Todd MB, Malech HL and Bertino JR (1985) Isolation and functional effects of monoclonal antibodies binding to thymidylate synthase. Biochemistry 24: 587-592
21. Johnston PG, Liang C, Henry S, Chabner BA and Allegra C (1991) Production and characterization of monoclonal antibodies that localise human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51: 6668-6676
22. Johnston PG, Drake JC, Trepel J and Allegra CJ (1992) Immunological quantitation of thymidylate synthase using the monoclonal antibody TS106 in 5-fluorouracil-sensitive and -resistant tumor cancer cell lines. Cancer Res 52: 4306-4312
23. Johnston PG, Drake JC, Steinberg SM and Allegra CJ (1993) Quantitation of thymidylate synthase in human tumors using an ultrasensitive enzyme-linked immunoassay. Biochem Pharmacol 45: 2483-2486
24. Johnston PG, Fisher E, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA and Allegra CJ (1994) The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12: 2640-2647
25. Johnston PJ, Lenz H-J, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L (1995) Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumours. Cancer R 55: 1407-1412
26. Jones M, Stracky J, Kelland LR and Harrap KR (1993) Acquisition of platinum drug resistance and platinum cross-resistance patterns in a panel of human ovarian carcinoma xenografts. Br J Cancer 67: 24-29
27. Leichman L, Lenz H-J, Leichman CG, Groshen S, Danenberg K, Baranda J, Spears CP, Boswell W, Silberman H, Onega A, Stain S, Beart R and Danenberg P (1995) Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an on-going trial. Ear J Cancer 31A: 1306-1310
28. Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214
29. Mulder NH, Timmer-Bosscha II, Meersma GJ and Vcrschueren RCJ (1994) Thymidylate sythase levels in tumor biopsies from patients with colorectal cancer. Anticancer Res 24: 2677-2680
30. Navalgund LG, Rossana C, Muench AJ and Johnson LF (1980) Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem 255: 7386-7390
31. Peters GJ, Van Groeningen CJ, Laurensse EJ and Pinedo H.M (1991) Thymidylate synthase from untreated human colorectal cancer and colonie mucosa; enzyme activity and inhibition by 5-fluoro-2'-deoxyuridine-5' -monophosphate. Eur J Cancer 27:263-267
32. Peters GJ, Van Der Wilt CL, Van Groeningen CJ, Smid K, Meijer S and Pinedo HM (1994a) Thymidylate synthase inhibition after administration of fluorouracil with and without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 12: 2035-2042
33. Peters GJ, Van Der Wilt CL and Van Groeningen CJ (1994ft) Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase. Eur J Cancer 10: 1408-1411
34. Peters GJ, Van Der Wilt CL, Van Triest B, Codacci-Pisanelli G, Johnston PG, Van Groeningen CJ and Pinedo HM ( 1995) Thymidylate synthase and drug resistance. EurJCancer 31A: 1299-1305
35. Sakamoto S, Ebuchi M and IwamaT (1993) Relative activities of thymidylate synthase and Ihymidine kinase in human mammary tumours. Anticancer Res 13: 205-20S
36. Sanguedolce R, Brumarescui I, Dardanoni G, Grassadonia A, Vultaggio G and Rausa L (1995) Thymidylate synthase level and DNA- ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study. Anticancer Res 15: 901-906
37. Spears CP, Antranik AH, Moran RG. Heidelberger C and Corbett TH (1982) In vivo kinetics of Ihymidylate synthase inhibition in 5-fluorouracil sensitive and - resistant murine colon adenocarcinomas. Cancer Res 42:450-456
38. Sotos G A, Girge L and Allegra CJ ( 1994) Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat Rev 20: 11-49
39. Suzuki M, Ohwada M, Tamada T and Tsuru S (1994) Thymidylate synthase activity as a prognostic factor in ovarian cancer. Oncology 51: 334-338
40. Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM and Allegra CJ (1989) Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 890-899
41. Van Der Wilt CL, Pinedo HM, Smid K and Peters GJ (1992) Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res 52:4922-1928
42. Van Der Wilt CL, Smid K, Aheme GW, Pinedo, UN and Peters GJ (1993) Evaluation of immunohistochemical staining and activity of thymidylate synthase in cell lines. In Advances in Experimental Medicine and Biology Ayling JL et al (eds), 338: 605-608, Plenum Publishing Corporation
43. Volm M and Mattem J (1992) Elevated expression of thymidylate synthase in doxorubicin resistant human non small cell lung carcinomas. Anticancer Res 12:2293-2296
44. Volm M, Zintl F and Sauerbrey A (1994) Thymidylate synthase in childhood acute non-lymphoblastic leukaemia. Anticancer Res 14: 1271-1276
45. Zeng Z-S, Sarkis AS, Zhang Z-F, Klimstro DS, Charytonowicz E, Guillem JG, Cordon-Cado C and Cohen AM (1994) p53 nuclear overexpression: an independent predictor of survival in lymph-positive colorectal cancer patients. J Clin Oncol 12: 2043-2050